(142 days)
The Pressure Monitoring Kit with TruWave Disposable Pressure Transducer is for use on patients requiring intravascular, intracranial, or intrauterine pressure monitoring.
The Edwards Lifesciences Pressure Monitoring kit with TruWave disposable pressure transducer is a sterile, single-use kit that monitors intravascular blood pressure, intracranial pressure, and intrauterine pressure. The disposable sterile cable (available in 12-inch/30 cm and 48-inch/120 cm lengths) interfaces exclusively with an Edwards Lifesciences cable that is specifically wired for the patient monitor used to display the pressure data.
The TruWave disposable pressure transducer has a straight, flow through design, where the fluid is passed across the pressure sensor. The DPT is available either with or without an integral flush device.
The provided text is a 510(k) summary for a medical device, the TruWave Disposable Pressure Transducer. It describes the device, its intended use, and the regulatory determination of substantial equivalence.
However, the provided text does not contain any information about acceptance criteria or a study proving the device meets acceptance criteria in the context of an AI/ML medical device, which is what the prompt is asking for. The device described (a pressure transducer) is a physical medical device, not an AI/ML algorithm.
Therefore, I cannot extract the requested information (acceptance criteria table, sample sizes, ground truth establishment, expert qualifications, adjudication methods, MRMC studies, standalone performance, training set details) from the provided document as it is not relevant to an AI/ML device study.
The document discusses:
- Device Name: TruWave Disposable Pressure Transducer
- Regulation Number: 21 CFR 870.2870 (Catheter Tip Pressure Transducer)
- Indications for Use: For patients requiring intravascular, intracranial, or intrauterine pressure monitoring.
- Substantial Equivalence: To predicate devices K171996 and K142749.
- Testing: Mentions "successfully passed biocompatibility and functional testing," but no details on the specific performance metrics or acceptance criteria for these tests are provided, nor is there any mention of AI/ML performance metrics. The "functional testing" broadly refers to the device's physical operation, not an AI algorithm's performance.
To answer your prompt, I would need a document detailing the clinical validation or performance study of an AI/ML medical device, including its acceptance criteria and how it was proven to meet them.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA acronym and name on the right. The FDA part of the logo is in blue, with the acronym "FDA" in a square and the words "U.S. FOOD & DRUG ADMINISTRATION" next to it.
May 1, 2019
Edwards Lifeciences, LLC Ye Seul Kim Senior Specialist, Regulatory Affairs One Edwards Way Irvine, California 92614
Re: K183413
Trade/Device Name: TruWave Disposable Pressure Transducer Regulation Number: 21 CFR 870.2870 Regulation Name: Catheter Tip Pressure Transducer Regulatory Class: Class II Product Code: DXO Dated: March 29, 2019 Received: April 1, 2019
Dear Ye Seul Kim:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for
{1}------------------------------------------------
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for
Matthew Hillebrenner Director (Acting) DHT2A: Division of Cardiac Electrophysiology, Diagnostics and Monitoring Devices OHT2: Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K183413
Device Name
TruWave Disposable Pressure Transducer
Indications for Use (Describe)
The Pressure Monitoring Kit with TruWave Disposable Pressure Transducer is for use on patients requiring intravascular, intracranial, or intrauterine pressure monitoring.
| Type of Use (Select one or both, as applicable) |
|---|
| ------------------------------------------------- |
|X Prescription Use (Part 21 CFR 801 Subpart D)
| | Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
SECTION 5 – 510(k) SUMMARY
| 510(k) Submitter | Edwards Lifesciences, LLC | |
|---|---|---|
| Contact Person | Primary Contact | Secondary Contact |
| Ye Seul KimSenior Specialist, Regulatory AffairsEdwards LifesciencesOne Edwards WayIrvine, CA 92614Tel: (949) 250 - 2445Fax: (949) 809 - 5425Email: yeseul_kim@edwards.com | Renate MacLarenSenior Manager, Regulatory AffairsEdwards LifesciencesOne Edwards WayIrvine, CA 92614Tel: (949) 250 - 5783Fax: (949) 809 – 2941Email: renate_maclaren@edwards.com | |
| Date Prepared | December 7, 2018 | |
| Trade Name | TruWave™ | |
| Common Name | Disposable Pressure Transducer | |
| ClassificationName | Transducer, pressure, catheter tip (21 CFR 870.2870) | |
| RegulationClass/ProductCode | Class IIDXO | |
| PrimaryPredicate Device | K171996, TruWave Disposable Pressure Transducer (cleared 10/23/2017) | |
| SecondaryPredicate Device | K142749, TruWave Disposable Pressure Transducer (cleared 01/18/2015) | |
| DeviceDescription | The Edwards Lifesciences Pressure Monitoring kit with TruWave disposable pressure transducer is a sterile, single-use kit that monitors intravascular blood pressure, intracranial pressure, and intrauterine pressure. The disposable sterile cable (available in 12-inch/30 cm and 48-inch/120 cm lengths) interfaces exclusively with an Edwards Lifesciences cable that is specifically wired for the patient monitor used to display the pressure data.The TruWave disposable pressure transducer has a straight, flow through design, where the fluid is passed across the pressure sensor. The DPT is available either with or without an integral flush device. | |
| Indications forUse/Intended Use | The Pressure Monitoring kit with TruWave disposable pressure transducer is for use on patients requiring intravascular, intracranial, or intrauterine pressure monitoring. | |
| ComparativeAnalysis | The subject device is identical to the predicate devices in terms of intended use/ indications for use, and technology. The proposed change to the device is a material change to a component of an existing legally | |
| marketed device. Testing was conducted to ensure that the change inmaterial did not alter the performance of the TruWave disposablepressure transducer. | ||
| The subject TruWave disposable pressure transducer has been shownto be substantially equivalent to the predicate devices for its intendeduse in hospitals and other appropriate clinical environments. | ||
| Functional/Safety Testing | The TruWave disposable pressure transducer kits successfully passedbiocompatibility and functional testing. | |
| Conclusion | The subject TruWave disposable pressure transducer kits aresubstantially equivalent to the predicate TruWave disposable pressuretransducer kits (K171996 and K142749). |
{4}------------------------------------------------
§ 870.2870 Catheter tip pressure transducer.
(a)
Identification. A catheter tip pressure transducer is a device incorporated into the distal end of a catheter. When placed in the bloodstream, its mechanical or electrical properties change in relation to changes in blood pressure. These changes are transmitted to accessory equipment for processing.(b)
Classification. Class II (performance standards).